- Home
- UPB vs INGM Comparison
UPB vs INGM Comparison
Compare UPB & INGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPB
- INGM
- Stock Information
- Founded
- UPB 2021
- INGM 1979
- Country
- UPB United States
- INGM United States
- Employees
- UPB N/A
- INGM N/A
- Industry
- UPB
- INGM
- Sector
- UPB
- INGM
- Exchange
- UPB NYSE
- INGM NYSE
- Market Cap
- UPB 521.3M
- INGM N/A
- IPO Year
- UPB 2024
- INGM 2024
- Fundamental
- Price
- UPB $11.15
- INGM $20.83
- Analyst Decision
- UPB Strong Buy
- INGM Strong Buy
- Analyst Count
- UPB 4
- INGM 14
- Target Price
- UPB $56.50
- INGM $25.69
- AVG Volume (30 Days)
- UPB 504.0K
- INGM 381.0K
- Earning Date
- UPB 08-14-2025
- INGM 08-15-2025
- Dividend Yield
- UPB N/A
- INGM 1.48%
- EPS Growth
- UPB N/A
- INGM N/A
- EPS
- UPB N/A
- INGM 1.25
- Revenue
- UPB $2,296,000.00
- INGM $48,929,580,000.00
- Revenue This Year
- UPB N/A
- INGM $6.50
- Revenue Next Year
- UPB N/A
- INGM $3.11
- P/E Ratio
- UPB N/A
- INGM $16.52
- Revenue Growth
- UPB N/A
- INGM 2.35
- 52 Week Low
- UPB $5.14
- INGM $14.25
- 52 Week High
- UPB $29.46
- INGM $25.69
- Technical
- Relative Strength Index (RSI)
- UPB N/A
- INGM N/A
- Support Level
- UPB N/A
- INGM N/A
- Resistance Level
- UPB N/A
- INGM N/A
- Average True Range (ATR)
- UPB 0.00
- INGM 0.00
- MACD
- UPB 0.00
- INGM 0.00
- Stochastic Oscillator
- UPB 0.00
- INGM 0.00
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.